AI to revolutionise drug development by 2026
CPHI's Annual Report 2023 for the first time reveals that…
CPHI's Annual Report 2023 for the first time reveals that pharmaceutical ‘AI companies’ have overtaken ‘late stage’ as the industry’s most appealing investment option for venture capital (VCs).